Pure Global

QUANTUM BLUE® FCAL EXTENDED, QUANTUM BLUE® ADALIMUMAB, QUANTUM BLUE® INFLIXIMAB. - DIGEMID Registration DMDIV5630E

Access comprehensive regulatory information for QUANTUM BLUE® FCAL EXTENDED, QUANTUM BLUE® ADALIMUMAB, QUANTUM BLUE® INFLIXIMAB. in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV5630E and manufactured by BÜHLMANN LABORATORIES AG. The device was registered on July 10, 2024.

This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.

Free Database
Powered by Pure Global AI
DIGEMID Official Data
DMDIV5630E
QUANTUM BLUE® FCAL EXTENDED, QUANTUM BLUE® ADALIMUMAB, QUANTUM BLUE® INFLIXIMAB.
DIGEMID ID: DMDIV5630E
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type
IN VITRO MEDICAL DEVICE
Registration Information
Analysis ID
DMDIV5630E
Registration Date
July 10, 2024
Expiration Date
July 10, 2029
Creation Date
February 17, 2025
Authorized Representative